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Insights From Optical Coherence TomographySandeep Basavarajaiah, MD,* Toru Naganuma, MD,y Mamoon Qadir, MD*A 33-year-old man presented with chest painand dynamic ST-segment elevation in theanterior leads. Coronary angiography re-
vealed dissection in the mid-segment of the leftFIGURE 1 Coronary Angiogram of the Left Coronary System
The coronary angiogram demonstrates dissection in the mid-segment of
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Video 1). This was conﬁrmed on the subsequentlythe LAD with luminal compression (Online Video 1). The arrows
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FIGURE 2 OCT Images Before Angioplasty
(A) Proximal reference, (B) MLA site, (C) hematoma site, (D) dissection ﬂap, (E) distal reference. MLA ¼ minimal lumen area; OCT ¼ optical coherence
tomography.
Basavarajaiah et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 9 , N O . 1 , 2 0 1 6
BVS in Dissection J A N U A R Y 1 1 , 2 0 1 6 : e 5 – 9
e6performed optical coherence tomography (OCT)
(Figure 2). Given his young age, we deployed 2 over-
lapping bioresorbable vascular scaffolds (BVS)
(3.0  18 mm and 3.5  28 mm), achieving good
angiographic and OCT results (Figure 3, Online
Video 2). Despite this, we were concerned about the
hematoma segment, that scaffolds may become mal-
apposed following hematoma resolution. So, we
reimaged the LAD 5 months later, which showed
continued good results on angiogram, but moreimportantly, the OCT revealed the absence of any
malapposed scaffolds (Figure 4, Online Videos 3, 4,
5, and 6). The OCT measurements have revealed
higher values at follow-up than measured following
angioplasty, indicating expansion of the scaffolds
(Figure 5). Furthermore, the average measurements
carried out at every millimeter length in the hema-
toma segment have also demonstrated similar ﬁnd-
ings. The average values post-procedure and at
follow-up were:
FIGURE 3 Coronary Angiogram and OCT Images Post-BVS Exhibiting Well-Apposed Scaffolds
Also see Online Video 2. BVS ¼ bioresorbable vascular scaffold; OCT ¼ optical coherence tomography.
FIGURE 4 Coronary Angiogram and OCT Images Post-Angioplasty and at 5 Months
Also see Online Videos 3, 4, 5, and 6. OCT ¼ optical coherence tomography.
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FIGURE 5 OCT Images Post-Angioplasty and at 5 Months and in Addition Signs of Scaffold Expansion
LCX ¼ left circumﬂex coronary artery; LM ¼ left main coronary artery; other abbreviations as in Figures 1 and 2.
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e8 Inner BVS area: 6.4  0.6 mm2 versus 7.1  0.5 mm2
 Inner BVS diameter: 2.8  0.1 mm versus 3.0 
0.1 mm
 Outer BVS area: 8.3  0.7 mm2 versus 8.5  0.5 mm2
 Outer BVS diameter: 3.2  0.1 mm versus 3.3 
0.1 mm
Use of BVS is ideal in young patients requiring
long-segment stenting especially in the LAD. Malap-
posed stent struts following hematoma resolution
have been reported in drug-eluting stents, which in-
creases the risk of stent thrombosis by creation ofdead space (1,2). Our case demonstrated that use of
BVS is safe in dissection, and OCT images have
revealed expansion of scaffolds post-hematoma res-
olution. This is an important ﬁnding and should
encourage use of BVS in such scenarios.
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APPENDIX For supplemental videos and
their legends, please see the online version of
this article.
